Programmed cell death-ligand 1 expression and immunoscore in stage II and III non-small cell lung cancer patients receiving adjuvant chemotherapy

10.18632/oncotarget.18651 ◽

2017 ◽

Vol 8 (37) ◽

pp. 61618-61625 ◽

Author(s):

Hidenobu Ishii ◽

Koichi Azuma ◽

Akihiko Kawahara ◽

Norikazu Matsuo ◽

Takaaki Tokito ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

PROGRAMMED CELL DEATH-LIGAND 1 EXPRESSION AND IMMUNOSCORE IN STAGE II AND III NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY

Respirology ◽

10.1111/resp.13207_73 ◽

2017 ◽

Vol 22 ◽

pp. 113-113

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non–Small-Cell Lung Cancer Patients

Clinical Lung Cancer ◽

10.1016/j.cllc.2017.02.004 ◽

2017 ◽

Vol 18 (5) ◽

pp. 572-582.e1 ◽

Author(s):

Kazuki Takada ◽

Gouji Toyokawa ◽

Tatsuro Okamoto ◽

Mototsugu Shimokawa ◽

Yuka Kozuma ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Comprehensive Analysis ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Association between continuous decrease of plasma VEGF-A levels and the efficacy of chemotherapy in combination with anti-programmed cell death 1 antibody in non-small cell lung cancer patients

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2020.100249 ◽

2020 ◽

Vol 25 ◽

pp. 100249

Author(s):

Takehiro Tozuka ◽

Noriko Yanagitani ◽

Hiroaki Sakamoto ◽

Hiroshi Yoshida ◽

Yoshiaki Amino ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Programmed Cell Death 1

Download Full-text

Faculty Opinions recommendation of Randomized Adjuvant Chemotherapy of EGFR-Mutated Non-Small Cell Lung Cancer Patients with or without Icotinib Consolidation Therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725853745.793510697 ◽

2015 ◽

Author(s):

Alexandru Grigorescu

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Consolidation Therapy ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Download Full-text

Feasibility of postoperative adjuvant chemotherapy using carboplatin plus S-1 in completely resected non-small cell lung cancer patients

Journal of Chemotherapy ◽

10.1080/1120009x.2019.1651002 ◽

2019 ◽

Vol 31 (6) ◽

pp. 343-348 ◽

Author(s):

Masayoshi Inoue ◽

Hidenori Kusumoto ◽

Hiroyuki Shiono ◽

Yasushi Shintani ◽

Naoko Ose ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Postoperative Adjuvant Chemotherapy ◽

Lung Cancer Patients

Download Full-text

Adjuvant chemotherapy benefits older and younger non-small cell lung cancer patients alike

CA A Cancer Journal for Clinicians ◽

10.3322/caac.21151 ◽

2012 ◽

Vol 62 (5) ◽

pp. 279-280 ◽

Author(s):

Mary Kay Barton

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy

Tumor Biology ◽

10.1007/s13277-010-0131-8 ◽

2010 ◽

Vol 32 (2) ◽

pp. 381-390 ◽

Author(s):

Yan Shi ◽

Li Chen ◽

Jie Li ◽

Ya-Li Lv ◽

Qiong Sun ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Predictive Values ◽

Lung Cancer Patients

Download Full-text

Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with Pembrolizumab

JMA Journal ◽

10.31662/jmaj.2019-0005 ◽

2019 ◽

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Adverse Events ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Cell Death Protein

Download Full-text

Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients

Lung Cancer ◽

10.1016/j.lungcan.2019.04.024 ◽

2019 ◽

Vol 133 ◽

pp. 75-82 ◽

Author(s):

Xiao Li ◽

Chao Zhang ◽

Zewen Sun ◽

Fan Yang ◽

Rongxin Xiao ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Stage Ib ◽

Download Full-text

Advanced non-small cell lung cancer patients with low tumor mutation burden might derive benefit from anti-programmed cell death (PD)-1 and anti-programmed deathligand 1 (PD-L1) blockade

Annals of Oncology ◽

10.1093/annonc/mdz063.068 ◽

2019 ◽

Vol 30 ◽

pp. ii62

Author(s):

W. Nie ◽

M.-D. Xu ◽

L. Gan ◽

Y. Zhang ◽

B.-H. Han

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell Lung ◽

Tumor Mutation Burden ◽

Lung Cancer Patients ◽

Mutation Burden

Download Full-text